The NUP98-HOXD13 transgenic model (NHD13) recapitulates many of the salient features of MDS, including neutropenia, lymphopenia and hypercellular or normocellular bone marrow at 4–7 months13, 14, 15, 16. Here, HOXD13 is linked to lymphopenia.